Article 13 Oct 2025 FDA Continues Focus On AI Fronts, Seeks Public Comment On Measuring And Evaluating AI-enabled Medical Device Performance In The Real-World United States Healthcare
Article 29 Sep 2025 FDA's Latest On Emergency Diagnostics And A No-Frills Rescission Of The LDT Rule United States Healthcare
Article 16 Sep 2025 From Foods To Pharmaceuticals, MAHA Strategy Offers Broad Menu Of FDA Actions United States Healthcare
Article 10 Sep 2025 FDA Continues Focus On Rare Disease Drug Development, Announces Evidence Principles United States Healthcare
Article 28 Aug 2025 OMUFA Reauthorization On Deck As Congress Returns From Recess United States Healthcare
Article 22 Jul 2025 FDA Announces AI Councils Amid Calls For Greater Agency Transparency United States Technology
Article 15 Jul 2025 FDA Opens The Vault On Decision Letters—Releases Wave Of Drug And Biologic CRLs United States Healthcare
Article 25 Jun 2025 FDA Announces Commissioner's National Priority Voucher Program To Accelerate Drug Application Review Process And Support National Priorities United States Healthcare
Article 09 Jun 2025 No Appeal Of LDT Decision Means Ball Is Back In FDA's Court For Policy Clarification United States Healthcare